0001846639-24-000001.txt : 20240131
0001846639-24-000001.hdr.sgml : 20240131
20240130210737
ACCESSION NUMBER: 0001846639-24-000001
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240131
DATE AS OF CHANGE: 20240130
EFFECTIVENESS DATE: 20240131
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valliance Asset Management Ltd
CENTRAL INDEX KEY: 0001846639
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: K3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-21042
FILM NUMBER: 24580382
BUSINESS ADDRESS:
STREET 1: 16/F, 8 QUEEN'S ROAD
CITY: CENTRAL
STATE: K3
ZIP: 000000
BUSINESS PHONE: 852 35657001
MAIL ADDRESS:
STREET 1: 16/F, 8 QUEEN'S ROAD
CITY: CENTRAL
STATE: K3
ZIP: 000000
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
false
false
false
0001846639
XXXXXXXX
12-31-2023
12-31-2023
Valliance Asset Management Ltd
16/F, 8 QUEEN'S ROAD
CENTRAL
K3
000000
13F HOLDINGS REPORT
028-21042
000310059
802-119486
N
Larri Harold BALLIN
Chief Compliance Officer
(852) 35657005
Larri Harold BALLIN
Hong Kong
K3
01-25-2024
0
6
2828704
false
INFORMATION TABLE
2
Valliance_13F_12312023.xml
FIVE9 INCCOM3383071014878786200SHSOLE620000HH&L ACQUISITION CO*W EXP 02/04/202G3971412910000400000SHSOLE40000000MONGODB INCCL A60937P1064906201200SHSOLE120000NVIDIA CORPORATIONCOM67066G1049904402000SHSOLE200000YS BIOPHARMA CO LTD*W EXP 03/15/202G9845F11728500750000SHSOLE75000000YS BIOPHARMA CO LTDORDINARY SHARESG9845F1098212661607175SHSOLE160717500